Achieve $800 million in cost savings by the end of next year.

Quote






Bye, bye employees. Tax restructuring. It's all a shell game though. Soap box cars still go a long way after they run out of hill. The do eventually come to a stop. Good luck all.
 












The full story on this is:

The deal is expected to close in the third quarter of this year. Valeant said it expects to realize at least $800-million in annual cost savings by the end of 2014. Mr. Pearson said much of that will come from eliminating corporate and headquarters functions and duplicate distribution costs.

This might mean that the entire facility in Rochester NY will be closed down. Eliminate corporate headquarters? What the hell does that mean?
 






Anonymous said:
The full story on this is:

The deal is expected to close in the third quarter of this year. Valeant said it expects to realize at least $800-million in annual cost savings by the end of 2014. Mr. Pearson said much of that will come from eliminating corporate and headquarters functions and duplicate distribution costs.

This might mean that the entire facility in Rochester NY will be closed down. Eliminate corporate headquarters? What the hell does that mean?
Click to expand...

Ask any Biovail HQ people what it means. Pearson is all about slashing administrative costs. Beyond that, he has no substance or fresh ides for the pharma industry. An industry he isnèt even part of. Valeant after all is an M&A company.
 






It means that reps with years of service and high salaries will be slashed for younger and hungrier reps just wanting a job and willing to be paid half as much. Expect the cuts to come fast and swift. Do what's in your best interest because B+L has already decided what's in their best interest-and it doesn't include 99% of us.
 






Top Bottom
Back
Quote